Hydroxyproline excretion in malignant neoplastic disease
- 1 December 1966
- journal article
- research article
- Published by American Medical Association (AMA) in Archives of internal medicine (1960)
- Vol. 118 (6) , 565-571
- https://doi.org/10.1001/archinte.118.6.565
Abstract
Research from JAMA Internal Medicine — Hydroxyproline Excretion in Malignant Neoplastic DiseaseThis publication has 17 references indexed in Scilit:
- Hydroxyproline and Collagen Metabolism: Clinical Implications: Combined Clinical Staff Conference at the National Institutes of HealthAnnals of Internal Medicine, 1965
- The Effect of Prednisone on Calcium Metabolism and Ca47 Kinetics in Patients with Multiple Myeloma and Hypercalcemia *Journal of Clinical Investigation, 1964
- Correlation of urinary hydroxyproline, serum alkaline phosphatase and skeletal calcium turnoverMetabolism, 1964
- Isotopic Studies on Collagen Degradation and the Urine Excretion of Hydroxyproline *Journal of Clinical Investigation, 1964
- Renal Tubular Transport of Proline, Hydroxyproline, and Glycine in Health and in Familial Hyperprolinemia *Journal of Clinical Investigation, 1964
- Urinary Hydroxyproline Excretion in Normal Children and Adolescents.Experimental Biology and Medicine, 1964
- An oral gelatin-xylose test for estimating pancreatic proteolytic activityDigestive Diseases and Sciences, 1963
- Urinary Hydroxyproline as an Index of Collagen Turnover in BoneNew England Journal of Medicine, 1963
- HYDROXYPROLINE EXCRETION IN ENDOCRINE DISEASE1963
- EXCRETION OF HYDROXYPROLINE IN PATIENTS WITH RHEUMATIC AND NON-RHEUMATIC DISEASES 1Journal of Clinical Investigation, 1956